split-virion, non-adjuvanted H1N1 vaccine of 30 μg
Sponsors
Jiangsu Province Centers for Disease Control and Prevention, Shanghai Institute Of Biological Products
Conditions
InfluenzaOrthomyxoviridae InfectionsRespiratory Tract DiseasesRespiratory Tract InfectionsVirus Diseases
Phase 2
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older
CompletedNCT00975572
Start: 2009-07-31End: 2010-02-28Updated: 2012-09-12
The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine
CompletedNCT01336166
Start: 2009-07-31End: 2011-07-31Updated: 2018-09-11